ϩ channel (mitoKATP) and its regulation by PKC are critical events in preconditioning induced by ischemia or pharmaceutical agents in animals and humans. The properties of the human cardiac mitoKATP channel are unknown. Furthermore, there is no evidence that cytosolic PKC can directly regulate the mitoKATP channel located in the inner mitochondrial membrane (IMM) due to the physical barrier of the outer mitochondrial membrane. In the present study, we characterized the human cardiac mitoKATP channel and its potential regulation by PKC associated with the IMM. IMM fractions isolated from human left ventricles were fused into lipid bilayers in symmetrical potassium glutamate (150 mM). The conductance of native mitoKATP channels was usually below 80 pS (ϳ70%), which was reduced by ATP and 5-hydroxydecanoic acid (5-HD) in a dose-and time-dependent manner. The native mitoKATP channel is activated by diazoxide and inhibited by ATP and 5-HD. The PKC activator phorbol 12-myristate 13-acetate (2 M) increased the cumulative open probability of the mitoKATP channel previously inhibited by ATP (P Ͻ 0.05), but its inactive analog 4␣-phorbol 12,13-didecanoate had no effect. Western blot analysis detected an inward rectifying K ϩ channel (Kir6.2) immunoreactive protein at 56 kDa and PKC-␦ in the IMM. These data provide the first characterization of the human cardiac mitoK ATP channel and its regulation by PKC(s) in IMM. This local PKC control mechanism may represent an alternative pathway to that proposed previously for cytosolic PKC during ischemic/pharmacological preconditioning.
bilayers; mitochondria; protein kinase C; ischemia; preconditioning THE MITOCHONDRIAL ATP-sensitive K ϩ (mitoK ATP ) channel was first discovered in the inner membrane (IMM) of rat liver mitochondria (21) . Subsequent studies have confirmed its presence by patch-clamp studies of the mitoplasts (11, 13) or IMM reconstituted in lipid bilayers (1, 5, 27, 28, 31, 45) . However, the unitary conductance of the putative mitoK ATP channel reported in these studies differed significantly, varying between ϳ10 and 100 pS. Equally controversial is the proposed molecular composition of the mitoK ATP channel (1, 27) . Several groups have even questioned the very existence of mitoK ATP , based on the measurement of mitochondrial K ϩ fluxes or volume change (7, 12) . In humans, the mitoK ATP channel was detected in a T-lymphocyte cell line (11) , but the existence and properties of human cardiac mitoK ATP channel have not been reported.
Numerous pharmacological studies have shown that the mitoK ATP channel plays a critical role in myocardial protection, induced by ischemic (15) and pharmacological preconditioning (14, 39, 44) . Ischemic preconditioning (IPC) triggers the translocation of PKC isoforms, such as ␦ or ⑀, from the cytosolic to the particulate fraction containing the mitochondria (33, 42, 43) . The translocated PKC has been proposed to regulate the mitoK ATP channel, and blockade of the PKC transfer prevents IPC in both animals and humans (20, 38, 42, 43) . Activation of the mitoK ATP channel by phorbol 12-myristate 13-acetate (PMA), a PKC activator, was found to protect the integrity of isolated mitochondria by preventing the opening of permeability transition pore and cytochrome-c release to simulated ischemia (24) . Furthermore, there is evidence that PKC activation by PMA potentiates the effect of diazoxide on flavoprotein oxidation, an indirect indicator of mitoK ATP channel activity (35) . Although these studies suggest a role of PKC in preconditioning, there is no evidence that the mitoK ATP channel is directly regulated by cytosolic PKC or other protein kinases due to the physical barrier of outer mitochondrial membrane (OMM). Costa et al. (9) proposed that phosphorylation of a target protein on OMM by protein kinase G (PKG) transmits the cardioprotective signals to PKC-⑀ located in the intermembrane space during preconditioning. On the other hand, it is possible that the mitoK ATP is regulated by local protein kinase(s) associated with IMM or intermembrane space.
The purpose of our study was to characterize human cardiac mitoK ATP channel and to investigate its potential regulation by a local PKC control mechanism. Reconstitution of the human mitoK ATP channel in lipid bilayers, away from the cytosolic environment, allowed us to examine whether the mitoK ATP channel is directly regulated by PKC located within the IMM.
METHODS
Mitochondrial isolation. The Institutional Review Board for Clinical Studies at the Medical College of Wisconsin approved this study. The investigation conforms to the principles outlined in the Declaration of Helsinki. Human ventricular muscles were obtained from two nonfailing donor hearts from brain-dead patients. Human atria were obtained during cardiac surgery with informed consent. Cardiac mitochondria were isolated according to the procedure of Solem and Wallace (37), with modifications as described previously (28) . Briefly, tissues from the left ventricles or atria were cut into small pieces and homogenized in an ice-cold isolation buffer containing (in mM) 30 MOPS (pH 7.2), 200 mannitol, 50 sucrose, 5 KH 2PO4, and 1 EGTA and 0.1% BSA in the presence of a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). After centrifugation at 3,000 g for 20 min, the supernatant was centrifuged at 8,000 g to obtain mitochondria (the pellet). Mitochondria were suspended in 3% Percoll in 10% sucrose solution, layered over a 6% Percoll in 20% sucrose solution, and centrifuged at 20,000 g for 30 min. The pellet was resuspended with the isolation medium without EGTA and then stored on ice for preparation of IMM.
Preparation of IMMs. The submitochondrial fraction enriched with IMM was prepared as reported (6, 29) . The mitochondrial pellet was osmotically shocked by incubation in 10 mM phosphate buffer (pH 7.4) for 20 min and then in 20% sucrose for another 15 min. Membranes were sonicated (Dual Horn for model 550, Fisher Scientific, Hanover Park, IL) three times for 30 s and centrifuged at 8,000 g for 10 min. The supernatant, containing submitochondrial particles, was fractionated by using a continuous sucrose gradient (30% to 60%) and then centrifuged at 80,000 g overnight. The heavy fraction was resuspended with the isolation medium without EGTA and centrifuged at 380,000 g for 30 min. The final pellet, enriched in IMM, was resuspended in the isolation medium without EGTA and BSA and then stored at Ϫ80°C in small aliquots until use.
Reconstitution of mitoK ATP channels into lipid bilayers. The vesicles of IMM were reconstituted into lipid bilayers as reported previously (28) . Briefly, the IMMs were added to the cis chamber and fused into the lipid bilayers in a symmetrical solution containing (in mM) 30 MOPS (pH 7.4), 150 potassium glutamate, 1 EGTA, 1.03 CaCl2 (free Ca 2ϩ , 10 M), 0.05 K2ATP, and 0.5 MgCl2. Ag/AgCl electrodes were placed into each chamber via agar salt (0.5 M KCl) bridges, and the trans chamber was connected to the head stage of a bilayer clamp amplifier (BC-525C, Warner Instrument, Hamden, CT). The cis chamber was held at virtual ground. Experiments were performed at room temperature. After incorporation of cation channel(s), single channel currents at a holding potential of ϩ30 or ϩ40 mV (trans/cis, Ϫ30 or Ϫ40 mV by convention) or as indicated were collected by using an Axon Digidata 1332 AD/DA interface (Axon Instruments, Union City, CA) with pClamp software (version 8.01, Axon Instruments). The currents were filtered at 0.5 kHz with an eight-pole Bessel filter and digitized at 2.5 kHz. The channel activity, accumulated over 2 to 4 min, was expressed as cumulative channel open probability (NPo), where N is the apparent number of channels, and Po is the mean open-state probability. NPo was determined from amplitude histograms after multiple Gaussian curve fitting (Origin 6.0, Microcal Software, Northampton, MA), as described previously (28) .
Western blot analysis. Western blot analysis assays for sarcolemmal KATP (sarcKATP) channel subunits in mitochondria were conducted as described previously (22) using a 4 -20% gradient Criterion Precast Gel (Bio-Rad), and that for PKC isoforms were done by using 7.5% Criterion Precast Gel (Bio-Rad) as described elsewhere (36) . The antibodies were obtained from Santa Cruz Biotechnology, including inward rectifying K ϩ channel (Kir)6.2 (G-16), Kir6.1 (C-16), sulfonylurea receptor (SUR)2 (C-15), SUR1 (C-16), PKC-⑀, PKC-␦, and PKC-␤. The secondary antibodies were conjugated with horseradish peroxidase. Detected proteins were visualized by using chemiluminescence. To ensure detection specificity, negative controls were done by using primary antibodies preabsorbed with immunogen peptides in a one-to-five ratio.
Characterization of mitoKATP channel reconstituted in lipid bilayers. MitoKATP channels were identified by their inhibition with ATP and 5-hydroxydecanoic acid (5-HD) and their activation by diazoxide, a mitoKATP channel opener. All modulators were added to the cis chamber and stirred for 30 s.
Effect of PMA on mitoKATP channel opening. After the appearance of K ϩ -conducting current in lipid bilayers, 0.5 mM ATP was used to screen ATP-sensitive channels. PMA (2 M) was added to the cis chamber while being stirred. The inactive phorbol ester 4␣-phorbol 12,13-didecanoate (PDD) was used as the negative control. Channel activities were monitored for up to 15 min, and the identity of mitoK ATP channels was confirmed at the conclusion of the experiment by their inhibition with 5-HD. Chemicals. The following drugs and chemicals were used: protease inhibitor cocktail, n-decane, MOPS, diazoxide, 5-HD, and ATP (Sigma-Aldrich); BSA (Serologicals, Milwaukee, WI); L-␣-phosphatidylethanolamine and L-␣-phosphatidyl-serine (Avanti PolarLipid, Alabaster, AL); and PMA and PDD (Calbiochem). PMA, PDD, and diazoxide were dissolved in DMSO before adding to the experimental solution. The final concentration of DMSO (Ͻ0.1%) alone did not exhibit any effect on channel current.
Statistical analysis. Because of significant variance in NP o between groups, data were analyzed after square root transformation and presented as means Ϯ SE. Multiple comparisons between groups were analyzed by analysis of variance, followed by Duncan's range tests. A value of P Յ 0.05 was considered significant.
RESULTS

Identification of human cardiac mitoK ATP channel.
The human IMM vesicles were fused into the lipid bilayers, and K ATP channels were identified based on their inhibition by ATP and/or 5-HD (15, 16, 32) , as well as on their activation by diazoxide, a putative agonist selective for the mitoK ATP channel (15, 18, 19) .
In the presence of 150 mM symmetrical potassium glutamate and at the holding potential of ϩ40 mV, recorded chord conductance of single mitoK ATP channels was mostly below 80 pS (n ϭ number of observations): ϳ20 pS (n ϭ 8), ϳ40 pS (n ϭ 8), ϳ60 pS (n ϭ 7), although the channel conductance Ͼ80 pS was also recorded (n ϭ 9). Figure 1A shows a K ϩ channel with a cord conductance of 65 pS at a holding potential of ϩ40 mV. The channel activity was abolished by 5-HD, confirming its identity as a mitoK ATP . Figure 1B shows original traces of another mitoK ATP recorded at varying holding potentials, and Fig. 1C illustrates its corresponding current-voltage relationship (I-V). Linear regression analysis revealed a slope conductance of 57 pS, similar to that observed for mitoK ATP from bovine (45) or rat hearts (28) . Figure 2A shows original traces of a mitoK ATP channel with a small conductance at various holding potentials. Its I-V curve is presented in Fig. 2B , and calculated slope conductance is 24 pS. We did not observe significant rectification within the range of voltages used, which probably can be better evaluated at higher voltages closer to a physiological range of matrix potential (ϳ180 mV). However, we were limited by the poor stability of artificial bilayers beyond Ϫ60 or ϩ60 mV, especially in patches with multiple channels.
The single channel conductance from patches with multiple mitoK ATP channels was often better appreciated in the presence of mitoK ATP inhibitors ATP or 5-HD. As shown in Fig. 3 , at baseline (control, Fig. 3A) , the observed peak current was ϳ6 pA at ϩ30 mV, with a small conductance channel opening at or above 0.75 pA (25 pS ). An addition of 0.5 mM ATP (Fig.  3B) inhibited most of the larger flickering channels, but the small channel remained mostly open. Increasing ATP to 1 mM (Fig. 3C ) gradually inhibited this channel until complete closure. Fig. 3C , inset, shows the segment of recordings with transition of the small conductance mitoK ATP from opening (at two levels, O 1 and O 2 ) to closing on an expanded scale. The This transition can also be observed in the presence of another blocker, 5-HD. Figure 4 shows regulation of mitoK ATP channels by ATP, GTP, and 5-HD from a different patch of IMM fused in bilayers. At baseline (Fig. 4A) , mitoK ATP channel openings were active; an addition of 0.5 mM ATP (Fig. 4B ) reduced the peak current by ϳ75% to give a smaller conductance of ϳ20 pS. An addition of 0.5 mM GTP (Fig. 4C) , a mitoK ATP channel agonist (32), markedly increased the peak current that exceeded that seen at baseline. 5-HD (200 M, Fig. 4D ) turned the sustained opening into a burst, with steplike conductance levels of ϳ40, 80, and 120 pS, as shown on an expanded scale (Fig. 4D, inset) . This was followed by complete closure (Fig. 4E) . Thus similar to ATP, 5-HD also caused a steplike closure of the channels, revealing multiple conductance states. These smaller conductance levels could arise from clusters of smaller channels, or they could represent subconductance states of the larger channels. Similar steplike behavior was also reported for sarcK ATP inhibited by glibenclamide (23) .
We also tested the effect of the mitoK ATP channel opener diazoxide on some mitoK ATP channels with low initial activities (NP o Ͻ 0.1). Data from multiple experiments are summarized in Fig. 5 . An addition of diazoxide (either 50 or 100 M) significantly increased NP o from the control levels (P Ͻ 0.05), and this current was subsequently blocked by 5-HD (200 M, P Ͻ 0.05 vs. diazoxide). These results confirmed the presence of mitoK ATP channels in native human IMM. The effects of diazoxide and 5-HD were similar to those reported in reconstituted bovine or rat cardiac K ATP channels (28, 45) . These concentrations were chosen because they produced consistent activation (diazoxide) or inhibition (5-HD) in preliminary studies. Similar concentrations were found to be effective for bovine (45) or rat mitoK ATP (28) channels.
Because the exact molecular composition of the mitoK ATP channel is not known, we explored its potential similarity to the sarcK ATP channel. We probed the isolated IMMs with antibodies targeting the subunits of sarcK ATP : the SUR (SUR1 and SUR2) and the Kir channel (Kir6.1 and Kir6.2). As shown in Fig. 6 (left), Kir6.2 antibody detected a 56-kDa peptide in human ventricular IMM and in two atrial mitochondrial preparations (Fig. 6, M) . The specificity was confirmed by preincubation of the antibody with its antigen peptide (Fig. 6, right) . Interestingly, this 56-kDa peptide is similar to the ethanolextracted 55-kDa mitochondrial protein reported by Miranova et al. (27) , which was proposed to be the mitochondrial inward rectifier subunit. However, we were not able to detect Kir6.1, as reported by Lacza et al. (25) , or SUR subunits with specificity (not shown).
Regulation of human cardiac mitoK ATP by local PKC. To explore whether human mitoK ATP channels are regulated by PKC associated with the IMM, we tested the effect of PKC activator PMA on mitoK ATP channels reconstituted into the lipid bilayers. Figure 7A shows the original recording of mitoK ATP openings at baseline (control), followed by inhibition with 0.5 mM ATP. An addition of PMA (2 M) in the cis chamber reactivated the channels that were eventually inhibited by 5-HD (400 M). In contrast to PMA, its inactive analog PDD had no effect (Fig. 7B) . Cumulative data from six separate observations are summarized in Fig. 7C . These results confirmed that PMA significantly increases the NP o of mitoK ATP channels previously inhibited by ATP (P Ͻ 0.05). The effects of PMA on mitoK ATP obtained at the singlechannel level are in agreement with the effect of PMA on the mitoK ATP activity in studies (9, 24) done on isolated mitochondria. Because the mitoK ATP channels reconstituted in lipid bilayers are in cytosol-free environment, no cytosolic PKC translocation was thus possible; the effect of PMA was likely mediated by PKC associated with the IMM. To confirm this hypothesis, we screened the IMM for PKC isozymes. As shown in Fig. 7C , inset, we were able to detect PKC-␦ but not PKC-⑀ (or ␤, not shown) in human IMM.
DISCUSSION
To our knowledge, this is the first study characterizing the human cardiac mitoK ATP channel and its modulation by PMA. Our results demonstrate that the mitoK ATP channels are present in human cardiac mitochondria, activated by diazoxide, and inhibited by ATP and 5-HD. Moreover, the mitoK ATP channels reconstituted in lipid bilayers can be directly stimulated by the PKC activator PMA without translocation of cytosolic kinases. Western blot analysis demonstrated that Kir6.2 immunoreactive protein and PKC-␦ are present in human IMM. These data suggest that the mitoK ATP channel is regulated locally by PKC associated with the IMM. This local control mechanism may serve as an alternative signal transduction pathway for the mitoK ATP channel activation during preconditioning to that proposed for PKC translocated from the cytosol to the mitochondria (33, 34, 41, 42) .
The existence of the mitoK ATP channel was first reported by Inoue et al. (21) in a patch-clamp study on liver mitoplasts. In the present study, we observed multiple conductances of the mitoK ATP channels (mostly below 80 pS), similar to previous observations in the rat heart (28). The conductance levels of these channels, however, are modulated by 5-HD as well as ATP. In mitochondria isolated from human lymphocyte cell line, Dahlem et al. (11) observed an outwardly rectifying K ϩ channel with a slope conductance of 82 pS at positive test potentials and 15 pS at negative test potentials. This channel, however, responded poorly to ATP inhibition: it was only partially inhibited by 12.5 mM ATP, whereas a higher ATP concentration had no effect. In our experiments, 0.5 mM or 1 mM ATP was effective in blocking most of the mitoK ATP channels.
A variety of mitoK ATP channel conductances have been reported since its initial discovery. In mitochondria from bovine hearts reconstituted in lipid bilayers, recorded mitoK ATP conductance was 30 pS (31) and 56 pS (45) . In mitoplasts prepared from rat cardiomyocytes, Er et al. (13) coworkers (4, 5) recorded the mitoK ATP channel with 103-pS conductance that was reduced by over 50% in the presence of 1 mM Mg 2ϩ . Different observations may result from differences in preparations, concentrations of charge carriers, as well as the presence of modulators such as Mg 2ϩ and ATP. They also reflect the complexity of studying the mitoK ATP channels and raise the possibility that there may be more than one type of channel that respond to known activators and inhibitors of mitoK ATP channels. Although we detected mitoK ATP channels at ϳ20 pS, channels with smaller conductance at ϳ10 pS could not be resolved under holding voltages used in our observations. Nevertheless, the results from our study revealed multiple conductance states of the human mitoK ATP channel. Whether they represent clusters of mitoK ATP channels or multiple-conducting states of a single channel has yet to be determined.
MitoK ATP channel has not yet been identified at the molecular level. Several studies (10, 25) that attempted to reveal its molecular structure relied on probing the mitochondria with antibodies against sarcK ATP subunits. However, this approach is often criticized due to lack of proper negative controls with antigen peptide competition, which may show false positive findings (7) . In the present study, anti-Kir6.2 antibody detected a 56-kDa protein in human cardiac IMM, but we failed to detect Kir6.1 and SUR subunits in the same sample with specificity. Garlid and coworkers (3, 27) have extracted the putative mitochondrial KIR and mitochondrial SUR from mitochondria and proposed a molecular structure similar to sarcK ATP (3, 27 ). An alternative molecular complex, which consists of five mitochondrial proteins within the IMM [the ATP binding cassette protein, a phosphate carrier, adenosine nucleotide translocator (ANT), ATP synthase, and succinate dehydrogenase], has been recently proposed (1) . Thus the definition of the mitoK ATP channel molecular nature remains far from resolved. Moreover, the very existence of the mitoK ATP channel has been challenged, based on measurements of mitochondrial volume change, K ϩ fluxes, and respiration in the presence of diazoxide or 5-HD (7, 12) .
Activation of the mitoK ATP channel by PKC has been considered a crucial event in cardiac preconditioning (17, 30) . Although it has been reported that PKC-⑀ translocates to the particulate fraction during IPC (33, 42, 43) , there is no evidence that cytosolic PKC isozymes can permeate the OMM and interact directly with the mitoK ATP in the IMM. The role of mitochondrial PKC in the mitoK ATP channel regulation was suggested in the study (24) on isolated mitochondria, which are devoid of cytosolic components. The authors of that study observed that PKC activation by PMA mimics the effect of diazoxide in preventing permeability pore transition, which was abolished by the mitoK ATP inhibitor 5-HD. Costa et al. (9) proposed that PKG may phosphorylate some target protein on the OMM and transmit the cardioprotective signals from cytosol to IMM via PKC-⑀ located in the intermembrane space. The evidence for this proposal, however, was based only on pharmacological studies in isolated mitochondria, using changes in mitochondrial volume and respiration as indirect indexes of the mitoK ATP channel activity.
In our experiments, PMA-activated mitoK ATP channels reconstituted in lipid bilayers, and we were able to detect PKC-␦ in IMM. These data suggest that PKC is associated with the IMM where it can directly activate mitoK ATP channels, probably by forming a signaling module. Further study is needed to investigate whether Kir6.2 is physically bound with PKC-␦ in IMM. PKC was previously shown to phosphorylate the Kir subunits in sarcK ATP (26) , and a similar mechanism may apply to mitoK ATP . This phosphorylation likely reduced the sensitivity of mitoK ATP to ATP inhibition, as well as 5-HD inhibition (Fig. 7) .
In the mitochondria, the role of PKC is not limited to regulating the mitoK ATP channels. PKC-␦ was also shown recently to bind specifically with pyruvate dehydrogenase and to prevent its reactivation during reperfusion (8) , although the source (cytosolic vs. mitochondrial) of the PKC remains elusive. PKC-⑀, although not detected in the present study with human IMM, has been shown to form a functional module with components of the permeability transition pore from mouse mitochondria, including the voltage-dependent anion channel (VDAC) located on the OMM and the ANT located on the IMM (2, 40) . The VDAC, located on the OMM, is obviously a better target for cytosolic kinases, such as PKCs, than the mitoK ATP located in the IMM. On the other hand, ANT may also form a part of the proposed mitoK ATP complex (1); its interaction with PKC-⑀ may also regulate mitoK ATP activity.
PKC-⑀ was also shown recently to interact with cytochrome-c oxidase (19) and with a scaffold protein cypher and ANT on the IMM (40) . This evidence suggests that PKC (and probably other kinases), located within the cardiac mitochondria, may play an important role in regulating respiration as well as ionic homeostasis. In the intact cell, a soluble second messenger, such as the diacylglycerol or reactive oxygen species, may activate mitochondrial PKC during IPC.
In summary, we have provided the first characterization of the human cardiac mitoK ATP channel and its regulation by PMA in vitro. Our data suggest that the mitoK ATP channel is activated by PKC associated with the IMM. This local control mechanism may represent an alternative regulatory pathway to that proposed for cytosolic PKC translocated to mitochondria during preconditioning. Further studies are needed to validate this local control mechanism.
